FDACounsel.com  -- Legal Services -- for the life of a Life Sciences company

MARKETED PRODUCT SERVICES

Advertising and Promotion
  ♦ Training
  ♦ SOP drafting and review
  ♦ Pre-release reviews
        • press releases
        • web sites
        • print and TV ads and scripts
Changes to Approved Products
  ♦ Regulatory Requirements counseling
        • Supplements
        • Annual Reports
  ♦ Implementation Tactics
FDA Regulatory Initiatives Impacting Marketed Products
  ♦ “Offensive” and "Defensive" Use of FDA Regulatory Process
        • Petitions
        • Comments on other actions
  ♦ Strategic responses
        • Comment preparation
        • Legislative responses
State Issues
  ♦ Drug Formulary
        • qualifying
        • challenges to listings
  ♦ Licensing Issues
        • manufacturing
        • pharmacy practice
  ♦ Compounding pharmacy regulation

Brand-Generic Competition Issues
   ♦ Non-patent product line extension
       • strategies to change innovator products
       • 505(b)(2) applications – major changes to
              approved products
   ♦ Legal “Blocking” of generic entry
       • altering the listed drug
       • legitimate scientific issues on equivalence
       • Hatch-Waxman market exclusivity eligibility
   ♦ Direct challenges to generic “equivalence”
Adverse Event Handling
   ♦ Regulatory classification of event
   ♦ Implementing
       • SOPs
       • Filings
Recalls
   ♦ Assessing need for recall
   ♦ Implementation
       • Risk classification process
       • Logistics
   ♦ Managing Products Liability Risks

For "Life Cycle" Stages Legal
Services, Just Click on The
Related Button Below ...

For "Any Time" Legal Services,
Just Click on The Related
Button Below ...

For "Product/Topic Specific"
Legal Services, Just Click on
The Related Button Below ...

To see presentations and articles on FDA issues involving
Marketed Products, just click here ...

© 2004 Law Offices of Michael A. Swit.  
ALL RIGHTS RESERVED.

Questions?

Contact us @ 760-815-4762
or
mswit@fdacounsel.com